Trial intelligence / Profile preview

Balloon aortic valvuloplasty without heparin to reduce vascular and bleeding complications

2012-003391-39Phase 4Terminated

Sponsor
Centre Hospitalier Universitaire de Montpellier
Start
Sep 2012
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of heparin in aortic stenosis (AS) (2 arms), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Serious procedure-related complications. Started Sep 2012; status: terminated.

02

Drugs

heparin
03

Conditions

aortic stenosis (AS)

Beyond the preview

Go deeper on 2012-003391-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003391-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call